Neuronetics STIM Income Statement (2017-2026)

NASDAQ STIM
$3.11 -0.03 (-0.96%)
At close: Aug 20, 2026 · 10:04 AM UTC
Income Statement Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue (Quarter)
13.80M15.02M14.18M16.33M16.50M18.20M15.54M17.61M17.88M20.31M17.42M16.45M18.53M22.49M31.98M38.11M37.30M41.78M34.45M41.57M
Cost of Revenue (Quarter)
3.14M3.54M3.48M4.04M3.57M4.39M4.14M4.84M6.12M4.54M4.33M4.27M4.53M7.60M16.24M20.35M20.19M20.07M18.30M20.34M
Gross Profit (Quarter)
10.65M11.48M10.70M12.29M12.93M13.81M11.40M12.77M11.76M15.77M13.09M12.18M14.00M14.89M15.74M17.76M17.11M21.70M16.15M21.22M
Operating items
Research & Development (Quarter)
1.57M10.31M12.65M13.69M2.35M3.14M2.79M11.56M12.14M-26.09M2.35M12.30M2.42M5.77M1.62M1.80M1.50M42.54M10.74M9.98M
Selling, General & Administrative (Quarter)
6.43M6.33M6.38M6.36M6.39M6.39M6.61M6.20M6.34M6.28M5.96M6.15M7.44M10.78M13.14M12.15M11.08M13.34M13.05M11.40M
Restructuring Costs (Quarter)
8.46M8.48M6.82M
Other Operating Expenses (Quarter)
9.83M1.74M1.80M2.04M11.64M12.01M11.90M2.36M2.15M40.01M11.64M2.23M11.88M9.81M3.53M11.87M11.85M-29.13M-7.12M-5.49M
Operating Expenses (Quarter)
17.84M18.39M20.83M22.09M20.38M21.54M21.30M20.12M20.64M20.20M19.95M20.69M21.73M26.36M26.75M25.82M24.43M26.75M25.15M22.72M
Operating Income (Quarter)
-7.18M-6.91M-10.13M-9.80M-7.45M-7.73M-9.91M-7.35M-8.87M-4.43M-6.86M-8.51M-7.73M-11.47M-11.01M-8.06M-7.32M-5.04M-8.99M-1.50M
EBIT (Quarter)
-7.18M-6.91M-10.13M-9.80M-7.45M-7.73M-9.91M-7.35M-8.87M-4.43M-6.86M-8.51M-7.73M-11.47M-11.01M-8.06M-7.32M-5.04M-8.99M-1.50M
Non-operating items
Other Non Operating Income (Quarter)
0.02M0.34M0.28M0.37M0.91M0.65M0.64M3.59M0.66M0.89M0.81M0.65M-4.40M-6.43M0.25M0.19M0.13M0.15M1.02M0.16M
Net income details
EBT (Quarter)
-12.79M-7.74M-15.27M-11.09M-8.71M-8.83M-11.16M-8.35M-10.05M-6.10M-8.69M-10.61M-9.45M-13.86M-13.09M-18.19M-12.10M-7.43M-11.26M-39.10M
Profit After Tax (Quarter)
-8.15M-7.64M-10.84M-10.42M-7.61M-8.33M-10.52M-4.90M-9.39M-5.39M-7.87M-9.83M-22.16M-12.68M-12.68M-9.84M-9.04M-7.16M-10.78M-3.46M
Income from Non-Controlling Interests (Quarter)
-0.01M0.28M-0.36M-0.05M0.01M-0.03M
Income from Continuing Operations (Quarter)
-12.79M-7.74M-15.27M-11.09M-8.71M-8.83M-11.16M-8.35M-10.05M-6.10M-8.69M-10.61M-9.45M-13.86M-13.09M-18.19M-12.10M-7.43M-11.26M-39.10M
Consolidated Net Income (Quarter)
-12.79M-7.74M-15.27M-11.09M-8.71M-8.83M-11.16M-8.35M-10.05M-6.10M-8.69M-10.61M-9.45M-13.86M-13.09M-18.19M-12.10M-7.43M-11.26M-39.10M
Income towards Parent Company (Quarter)
-12.79M-7.74M-15.27M-11.09M-8.71M-8.83M-11.16M-8.35M-10.05M-6.10M-8.69M-10.61M-9.45M-13.86M-13.09M-18.19M-12.10M-7.43M-11.26M-39.10M
Net Income towards Common Stockholders (Quarter)
-12.79M-7.74M-15.27M-11.09M-8.71M-8.83M-11.16M-8.35M-10.05M-6.10M-8.69M-10.61M-9.45M-13.86M-13.09M-18.19M-12.10M-7.43M-11.26M-39.10M
Additional items
EPS (Basic) (Quarter)
-0.49-0.30-0.57-0.41-0.32-0.33-0.40-0.29-0.35-0.21-0.29-0.35-0.31-0.44-0.21-0.27-0.18-0.11-0.16-0.53
EPS (Diluted) (Quarter)
-0.49-0.30-0.57-0.41-0.32-0.33-0.40-0.29-0.35-0.21-0.29-0.35-0.31-0.44-0.21-0.27-0.18-0.11-0.16-0.53
Shares Outstanding (Quarter)
26.30M25.48M26.60M26.79M26.96M26.90M28.03M28.59M28.88M28.66M29.47M30.05M30.27M31.73M61.47M66.18M67.31M65.95M69.59M73.13M
Shares Outstanding (Diluted) (Quarter)
26.30M25.48M26.60M26.79M26.96M26.90M28.03M28.59M28.88M28.66M29.47M30.05M30.27M31.73M61.47M66.18M67.31M65.95M69.59M73.13M
Shares Outstanding (Entity) (Quarter)
26.34M26.39M26.72M26.86M27.06M27.27M28.46M28.81M28.90M29.09M29.98M30.14M30.32M31.73M65.82M66.11M68.44M68.99M69.58M76.19M
EBITDA (Quarter)
-7.18M-6.91M-10.13M-9.80M-7.45M-7.73M-9.91M-7.35M-8.87M-4.43M-6.86M-8.51M-7.73M-11.47M-11.01M-8.06M-7.32M-5.04M-8.99M-1.50M
Interest Expenses (Quarter)
5.61M0.83M5.14M1.29M1.26M1.10M1.25M1.00M1.18M1.67M1.83M2.10M1.73M2.39M2.07M10.13M4.78M2.39M2.27M37.60M